dc.contributor.author |
van der Groen, G. |
en_US |
dc.date.accessioned |
2007-12-06T14:48:33Z |
|
dc.date.available |
2007-12-06T14:48:33Z |
|
dc.date.issued |
2001 |
en_US |
dc.identifier.issn |
0269-9370 |
en_US |
dc.identifier.other |
ITG-MUA |
en_US |
dc.identifier.other |
MICRO |
en_US |
dc.identifier.other |
U-VIROL |
en_US |
dc.identifier.other |
JIF |
en_US |
dc.identifier.uri |
http://hdl.handle.net/10390/2011 |
|
dc.description |
Not the final published version |
|
dc.language |
English |
en_US |
dc.publisher |
Lippincott, Williams & Wilkins |
|
dc.subject |
Viral diseases |
en_US |
dc.subject |
HIV |
en_US |
dc.subject |
AIDS |
en_US |
dc.subject |
Treatment |
en_US |
dc.subject |
Guidelines |
en_US |
dc.subject |
Antiretrovirals |
en_US |
dc.subject |
Prices |
en_US |
dc.subject |
Feasibility |
en_US |
dc.subject |
Follow-up |
en_US |
dc.subject |
Disease resistance |
en_US |
dc.subject |
Monitoring |
en_US |
dc.subject |
Developing countries |
en_US |
dc.title |
The urgent need for feasibility studies of antiretroviral treatment in HIV-infected individuals in resource-limited settings [letter] |
en_US |
dc.type |
Letter |
en_US |
dc.type |
Article |
en_US |
dc.citation.jtitle |
AIDS |
en_US |
dc.citation.volume |
15 |
en_US |
dc.citation.pages |
2342-2344 |
en_US |
dc.publisher.place |
Philadelphia |
|
dc.identifier.pmid |
http://www.ncbi.nlm.nih.gov/pubmed/11698717 |
|
dc.citation.jabbreviation |
AIDS |
en_US |